Allakos Inc. (ALLK)
May 15, 2025 - ALLK was delisted (reason: acquired by Concentra Biosciences)
0.3291
-0.0002 (-0.06%)
Inactive · Last trade price on May 14, 2025
Allakos Stock Forecast
ALLK's stock price has decreased by -73.02% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Allakos stock had an average target of 2.00, with a low estimate of 1.00 and a high estimate of 3.00.
Price Target: $2.00 (+507.72%)
Analyst Consensus: Hold
* Price targets were last updated on Sep 26, 2024.
Analyst Ratings
The average analyst rating for Allakos stock from 3 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $3 | Buy | Reiterates | $3 | +811.58% | Sep 26, 2024 |
| Jefferies | Jefferies | Hold Maintains $1.5 → $1 | Hold | Maintains | $1.5 → $1 | +203.86% | Jul 18, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $3 | Buy | Reiterates | $3 | +811.58% | Jun 26, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jun 20, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $10 → $3 | Buy | Maintains | $10 → $3 | +811.58% | Jan 17, 2024 |
Financial Forecast
Revenue This Year
n/a
from 7.55M
Revenue Next Year
n/a
EPS This Year
-0.62
from -1.30
EPS Next Year
-0.23
from -0.62
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.55 | -0.05 | -0.05 | ||
| Avg | -0.62 | -0.23 | -0.15 | ||
| Low | -0.74 | -0.32 | -0.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.